Abstract
Clinical trials have demonstrated a clinical benefit for cardiac resynchronization-defibrillator (CRT-D) and implantable cardioverter-defibrillator (ICD) therapies in patients with heart failure and reduced ejection fraction (HFrEF). Recently questions have been raised with regard to the benefit of ICDs for women. The purpose of this study was to determine the clinical effectiveness of CRT and ICD therapy as a function of sex in outpatients with HFrEF (≤35%).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
